Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$791K Buy
3,143
+437
+16% +$94K 0.06% 89
2026
Q1
$589K Buy
2,706
+107
+4% +$23.7K 0.05% 90
2025
Q4
$594K Buy
2,599
+322
+14% +$73.4K 0.05% 88
2025
Q3
$527K Sell
2,277
-37
-2% -$7.54K 0.04% 87
2025
Q2
$430K Buy
2,314
+44
+2% +$8.18K 0.04% 98
2025
Q1
$476K Sell
2,270
-371
-14% -$72.1K 0.05% 88
2024
Q4
$469K Sell
2,641
-1,036
-28% -$190K 0.05% 89
2024
Q3
$726K Buy
3,677
+1,528
+71% +$285K 0.08% 75
2024
Q2
$369K Buy
2,149
+658
+44% +$109K 0.05% 96
2024
Q1
$272K Buy
+1,491
New +$257K 0.04% 108

Other funds holding ABBV

One Day In July LLC's ABBV Position: Q2 2026 in Review

One Day In July LLC increased its AbbVie (ABBV) stake by 16% in Q2 2026, buying an estimated $94K and bringing the position to 3,143 shares worth $791K. The position accounts for 0.06% of the portfolio, ranked #89.

One Day In July LLC first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • One Day In July LLC held 3,143 shares of AbbVie worth $791K as of Q2 2026.
  • One Day In July LLC bought 437 AbbVie shares in Q2 2026, an estimated $94K.
  • AbbVie made up 0.06% of One Day In July LLC's portfolio in Q2 2026, its #89 holding.
  • One Day In July LLC first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on One Day In July LLC's 13F filing for Q2 2026, filed 3 Aug 2026.